Keyword: Active Pharmaceutical Ingredients (APIs)
News
15.11.2017
- US pharmaceutical giant Pfizer has divested its 49% stake in Hisun-Pfizer Pharmaceuticals its Chinese joint venture with Zhejiang Hisun Pharma. As part of the plan, Sapphire I...
News
17.10.2017
- Piramal Pharma Solutions (PPS) is spending $55 million across its sites in North America and Asia to expand its API manufacturing capacities and capabilities. “With these...
Logistics & Supply Chain
29.09.2017
- Emirates Skycargo has received a revalidation of the European Union Good Distribution Practices (EU GDP) certification for pharma operations at its hub in Dubai. The annual...
Plant Construction & Process Technology
27.09.2017
- There is a regulatory expectation that pharmaceutical companies will verify that the excipients produced by their suppliers are to an appropriate level of GMP. This has been...
Strategy & Management
27.09.2017
- 2017 marks the 200th anniversary of UK specialty chemical and technology group Johnson Matthey which – back in 1817 – began as assayers, testing the purity of precious metals. In...
Markets & Companies
27.09.2017
- The market for active pharmaceutical ingredients (APIs) is approximately $140 billion and is projected to reach nearly $190 billion by 2020. So what does the market show? The API...
Plant Construction & Process Technology
27.09.2017
- In the shifting pharmaceutical landscape, contract manufacturing organizations (CMOs) and big pharma could see significant benefits. The findings of a new A.T. Kearney study can...
News
22.08.2017
- US buyout group SK Capital Partners has opted not to sell Archroma, announcing it has reinvested in the Swiss producer of textile chemicals, paper specialties and emulsions, which...
